Premarket Mover: I-Mab ADR (IMAB) Down 3.51%

I-Mab ADR (IMAB) is down Wednesday morning, with the stock falling -3.51% in pre-market trading to 7.69. IMAB's short-term technical score of 36 indicates that the stock has traded less bullishly over the last month than 64% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, IMAB ranks higher than 48% of stocks. I-Mab ADR has fallen 10.95% over the past month, closing at $10.08 on July 20. During this period of time, the stock fell as low as $7.96 and as high as $10.82. IMAB has an average analyst recommendation of Strong Buy. The company has an average price target of $72.97.

IMAB has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on IMAB!

See Full IMAB Report

I-Mab ADR has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 83 by this metric, IMAB ranks better than 83% of stocks.

Important Dates for Investors in IMAB:

-We do not have a set earnings date for I-Mab ADR at this time. -We do not have a set dividend date for I-Mab ADR at this time. Click Here To Get The Full Report on I-Mab ADR (IMAB)